EastEnders star Nina Wadia shows off her incredible glow up and weight loss transformation as she lays into fat jabs

Nina Wadia recently revealed a striking transformation and weight loss, and openly discussed negative comments about her body in a new interview.

The 57-year-old actress, known for her role as Zainab Masood on EastEnders, claims that weight loss injections aren’t effective, explaining how she personally achieved her body transformation.

Nina shared that she’s really motivated to stay active as she works towards her weight loss goals.

The actress shared that she’s been making changes gradually. She’s been exercising, walking, and eating a healthier diet, believing this slower approach is more effective.

She shared her thoughts on vaccinations, explaining that lasting solutions aren’t quick fixes, but rather involve changes to everyday habits. She recently collaborated with the NHS on this topic.

Nina is partnering with the National Lottery’s This Girl Can campaign to encourage women to be active and exercise.

She told The Sun that staying active is crucial as people age, something she feels strongly about, and that it’s best done in a natural way.

These medications, first created to treat diabetes, are now used to help with weight loss. They work by acting like a natural hormone in your gut, which makes you feel fuller and reduces your appetite.

Approximately 2.5 million people in the UK are now estimated to be using weight-loss injections like Mounjaro and Ozempic.

A new trial is now happening in the UK, offering weight-loss injections to thousands of overweight people to help them return to work, according to officials.

A new trial in Greater Manchester will give doctors the ability to prescribe the drug Mounjaro to as many as 3,000 patients. This is the first study of its kind to test how the drug affects people’s everyday lives, including things like their ability to work and how often they need to take time off sick.

Research indicates that this new drug, known for its powerful fat-loss effects, can help people lose as much as 25% of their body weight in about a year and a half.

Eli Lilly, the maker of the drug, is funding the five-year trial with a £279 million investment, working alongside the Government.

As a lifestyle expert, I was really encouraged when the Health Secretary, Wes Streeting, announced this study last year. He highlighted how important it is – not just for improving our health as individuals, but for building a stronger economy and ensuring the NHS is ready to meet future challenges. It’s a fantastic step towards a healthier future for everyone.

The Prime Minister previously suggested that medications for weight loss could help get more people back into work and improve the country’s economic output, calling them a significant benefit to the economy.

Around two-thirds of adults in Britain are considered overweight or obese, and on average, people weigh about a stone (14 pounds) more now than they did three decades ago. This is costing the UK economy an estimated £100 billion each year.

According to Mark Fisher, head of NHS Greater Manchester, approximately 600,000 adults in the Greater Manchester area are living with obesity.

A recent report from Health Innovation Manchester estimated that obesity cost the region over £3 billion in 2023, including expenses for healthcare, social care, and reduced quality of life.

Dr. Imran Ghafoor, a partner at Peterloo Medical Centre in Middleton, explained to the BBC that patients feel comfortable with his practice because it’s a well-known and easy-to-reach location.

Research from the trial would help ‘test solutions tailored to real lives’, he added. 

Right now, these medications are only offered through the healthcare system to patients with severe obesity or multiple related health problems.

It means most users are forced to buy the drugs privately, at a cost of roughly £200 a month.

As part of the NHS’s recently released 10-year plan from July, government officials will collaborate with healthcare companies to try out new and better ways to help patients lose weight. These services and treatments will be offered in easily accessible locations, with a focus on both effectiveness and safety.

This could include ‘on the high street, or at any out-of-town shopping centre’.

Read More

2026-01-06 22:34